
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

UnitedHealth’s Optum to address pricing, access challenges for prescription drugs
The changes come as pharmacy benefit managers face scrutiny for how they require doctors and patients to seek its approval for certain treatments and drugs.

‘Rationing by inconvenience’: Health insurers count on customers not appealing denials
For many patients, the appeal process is just too much

Bruised by Government Report, Cigna's Pharmacy Business Sues the Federal Trade Commission
Whistleblower, former Cigna VP, and reformed insurance propagandist Wendell Potter takes you behind the scenes to provide a glimpse into the reasoning behind the lawsuit his former company filed this week against the Federal Trade Commission (FTC).

Minnesota legislation targets health insurers’ power to block medical care, medications
House bill would prevent redundant insurance red-tape for treatment of chronic diseases. The fate of prior authorization will be decided in the session’s final days.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.